Voluntis, a leader in digital therapeutics, and Bristol-Myers Squibb Company announced a collaboration agreement to create and investigate digital therapeutic solutions that will support cancer patients.
With an estimated 1.7 million new cases of cancer diagnosed every year in the United States, cancer management is one of the country’s leading health expenditure
A second mobile app developed by Pear Therapeutics to help opioid use disorder patients who have a more successful response to therapy has been given a green light by the FDA.